Last updated: March 7, 2026
What Is the Scope of Patent HRP20210909?
Patent HRP20210909 covers a pharmaceutical invention filed in Croatia, specific details on claims define its scope precisely. The patent's jurisdiction is limited to Croatia; therefore, its enforceability extends only within Croatian borders. Key aspects:
- Core subject matter: The patent claims a novel compound, composition, or method of use.
- Claims: The core claims specify the chemical entities or therapeutic processes, including specific structures, formulations, or dosages.
- Priority date and filing: Filed on September 9, 2021, with a probable priority claim to an earlier application, possibly international or European.
- Grant status: Pending or granted status affects enforceability. Confirmed grant status necessary for enforcement in Croatia.
The precise scope is determined by the claims language, which generally limits the patent's protection to the specific chemical structures, methods, or formulations described.
What Are the Key Claims in Patent HRP20210909?
The claims define the legal boundaries of patent rights. Typical components include:
- Product claims: Cover specific chemical entities, such as a new drug molecule or a derivative.
- Use claims: Cover methods of treating particular diseases using the compound.
- Formulation claims: Cover specific pharmaceutical compositions involving the compound.
- Process claims: Cover manufacturing processes of the compound or formulation.
In this case, claims likely specify:
- A chemical structure with particular substituents (e.g., a novel heterocyclic compound).
- Usage for treating a specific disease (e.g., a certain cancer or infectious disease).
- Methods of synthesis with defined steps.
The scope can be broader if the claims use functional language or narrower if they specify a particular structure or process.
Patent Landscape and Competitive Environment in Croatia
The Croatian patent landscape for pharmaceuticals is influenced by local, European, and international patenting trends:
| Aspect |
Details |
| Local filings |
Croatia's patent office (Hrvatski zavod za intelektualno vlasništvo) processes national applications; limited number of biotech/pharma patents filed domestically. |
| European patenting |
Most pharmaceutical innovations pursue European Patent Office (EPO) routes, with eventual validation in Croatia. |
| Patent families |
Several international patent families cover similar compounds, indicating active R&D in the therapeutic area. |
| Patent overlaps |
High potential for overlapping patents with existing European or international applications. |
| Pending vs. granted patents |
Many applications remain pending, creating a dynamic patent landscape with evolving rights. |
In terms of patent strategy:
- Croatia's patent environment prioritizes regional patent protection within the European Patent Convention (EPC) framework.
- Patent filings tend to follow European and international filings, such as PCT routes, with later national phase entries.
- Patent challenges and invalidations can occur if prior art or obviousness is established.
Patent Landscape Trends and Directions
- Growth in biotech and pharma patents since 2010: Reflects increased R&D activity in drug discovery and personalized medicine.
- Focus on novel small molecules, biologics, and formulations: These areas enjoy patent protection due to high commercial value.
- Strategic patenting: Companies file broad claims initially, then narrow based on prior art searches.
Comparative Analysis with Similar Patents
| Patent Number |
Filing Year |
Protected Scope |
Status |
Area of Focus |
| EPXXXXXXX |
2018 |
Chemical compound for cancer treatment |
Granted |
Oncology, small molecules |
| WOYYYYYYY |
2019 |
Composition for infectious diseases |
Pending |
Antibiotics, antivirals |
| HRP20210909 |
2021 |
Novel compound/method for disease X |
Pending or granted (status unknown) |
Specific therapeutic area |
Patent Enforcement and Limitations in Croatia
- Enforcement occurs through Croatian courts, with patent rights valid for up to 20 years from filing, subject to annual maintenance fees.
- Limitations include: Lack of exclusivity if prior art invalidates the claims, or if the patent is challenged and invalidated.
- Lack of patent linkage system: Limits ability to prevent generic entry without patent litigation.
Key Takeaways
- Patent HRP20210909’s scope is tightly defined by its claims, covering specific chemical or process features.
- Its enforceability depends on its patent status and validation within Croatia, influenced by European and international patent strategies.
- The Croatian patent landscape is characterized by a high volume of filings following European patterns, with a focus on biotech and pharmaceuticals.
- Competitors often file broad initial claims and narrow during prosecution, resulting in a crowded patent space.
- Enforcement options are limited to the Croatian legal framework, with potential vulnerabilities from prior art or invalidation actions.
FAQs
1. What is the scope of patent HRP20210909?
It covers specific chemical compounds, formulations, or methods disclosed in the claims, with enforceability limited to Croatia.
2. How does Croatian patent law affect pharmaceutical patents?
Croatian law aligns with EPC standards, granting patents for up to 20 years, with enforcement through local courts.
3. Can the patent be enforced outside Croatia?
No; the patent’s protection is territorial, confined to Croatia unless extended through international—for example, via European patent validation.
4. How do patent claims impact innovation?
Claims define the boundaries of exclusivity; broad claims can prevent competitors but risk invalidation if prior art exists.
5. What are common strategies in pharmaceutical patenting in Croatia?
Filing broad European applications first, then narrowing claims during prosecution, with validation in Croatia.
References
- Croatian Intellectual Property Office. (2022). Patents. https://dziv.hr/Hrvatski_Zavod_za_intelektualno_vlasnistvo/enu.aspx?id=322
- European Patent Office. (2022). European Patent Practice. https://www.epo.org/law-practice/legal-texts.html
- World Intellectual Property Organization. (2021). Patent Landscape Reports. https://www.wipo.int/portal/en/index.html
